By examining the presence of ACTBL2-positive TILs in 156 EOC specimens via immunohistochemistry we could demonstrate that the expression of ACTBL2 in leukocytes was remarkably higher than its level in the according tumor cells. This evidence concerns the gene ACTBL2 and neoplasm.